We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$28.5B
AUM Growth
-$1.64B
Cap. Flow
-$541M
Cap. Flow %
-1.9%
Top 10 Hldgs %
23.41%
Holding
1,182
New
104
Increased
354
Reduced
497
Closed
123

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$94.3M
2
MSFT icon
Microsoft
MSFT
+$65.5M
3
LLY icon
Eli Lilly
LLY
+$58.4M
4
NVDA icon
NVIDIA
NVDA
+$58M
5
ABBV icon
AbbVie
ABBV
+$43.8M

Top Sells

Rank Stock Value
1
SLAB icon
Silicon Laboratories
SLAB
+$84.9M
2
ATVI
Activision Blizzard
ATVI
+$78.4M
3
BAC icon
Bank of America
BAC
+$64.2M
4
MA icon
Mastercard
MA
+$60.4M
5
MMM icon
3M
MMM
+$55.1M

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.18%
3 Consumer Discretionary 12.28%
4 Financials 8.16%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLAC icon
101
KLA
KLAC
$222B
$66.5M 0.23%
1,449,000
+137,300
+10% +$6.58M
PGR icon
102
Progressive
PGR
$128B
$66M 0.23%
473,818
+37,473
+9% +$4.93M
SNPS icon
103
Synopsys
SNPS
$71.6B
$65.9M 0.23%
143,502
-6,584
-4% -$2.95M
CVS icon
104
CVS Health
CVS
$135B
$65.8M 0.23%
941,881
+76,020
+9% +$5.39M
CTSH icon
105
Cognizant
CTSH
$26.5B
$63.9M 0.22%
942,896
+154,529
+20% +$10.7M
CNMD icon
106
CONMED
CNMD
$1.3B
$62.9M 0.22%
623,851
-30,189
-5% -$3.47M
ICE icon
107
Intercontinental Exchange
ICE
$87.2B
$62.4M 0.22%
567,367
+40,135
+8% +$4.6M
KHC icon
108
Kraft Heinz
KHC
$32.8B
$62.3M 0.22%
1,852,099
+945,894
+104% +$32.7M
MRNA icon
109
Moderna
MRNA
$21.6B
$62.3M 0.22%
603,040
+109,999
+22% +$12.3M
BRK.B icon
110
Berkshire Hathaway Class B
BRK.B
$1.1T
$62.1M 0.22%
177,288
-15,587
-8% -$5.53M
CVX icon
111
Chevron
CVX
$382B
$61.6M 0.22%
365,046
+7,957
+2% +$1.29M
CYBR
112
DELISTED
CyberArk
CYBR
$60.1M 0.21%
367,173
+1,302
+0.4% +$209K
LRCX icon
113
Lam Research
LRCX
$316B
$60.1M 0.21%
958,930
-16,520
-2% -$1.09M
VZ icon
114
Verizon
VZ
$197B
$59.3M 0.21%
1,830,937
-113,058
-6% -$3.82M
PFE icon
115
Pfizer
PFE
$143B
$58.9M 0.21%
1,775,924
-33,683
-2% -$1.19M
GXO icon
116
GXO Logistics
GXO
$5.93B
$58.6M 0.21%
999,875
-46,055
-4% -$2.88M
AVB icon
117
AvalonBay Communities
AVB
$27.5B
$57.1M 0.2%
332,202
-16,084
-5% -$2.97M
EOG icon
118
EOG Resources
EOG
$77.7B
$57M 0.2%
449,844
+43,106
+11% +$5.48M
UBS icon
119
UBS Group
UBS
$170B
$56.3M 0.2%
2,285,273
-1,131,883
-33% -$26.4M
GMED icon
120
Globus Medical
GMED
$11.1B
$56.1M 0.2%
1,129,561
-362,625
-24% -$20.3M
NTAP icon
121
NetApp
NTAP
$33.9B
$55.6M 0.2%
732,250
+263,714
+56% +$20.4M
MDT icon
122
Medtronic
MDT
$112B
$55.6M 0.2%
709,022
+95,220
+16% +$7.97M
SLAB icon
123
Silicon Laboratories
SLAB
$7.14B
$55.6M 0.2%
479,338
-615,057
-56% -$84.9M
CME icon
124
CME Group
CME
$95.4B
$54.2M 0.19%
270,523
-16,389
-6% -$3.26M
TT icon
125
Trane Technologies
TT
$98.8B
$54.1M 0.19%
266,732
+11,842
+5% +$2.37M

Similar funds

Axa's Q3 2023 Portfolio in Review

As of Q3 2023, Axa held 1,182 positions worth $28.5B, down 5.5% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa's Q3 2023 filing shows 104 new, 354 increased, 497 reduced and 123 closed positions. Its largest new stake was Invesco: 1,126,202 shares worth $16.4M. The largest sale was Silicon Laboratories, an estimated $84.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2023 buy was Invesco: 1,126,202 shares worth $16.4M.
  • Axa added most to Applied Materials in Q3 2023, an estimated $94.3M increase.
  • Axa's biggest Q3 2023 reduction was Silicon Laboratories, cutting an estimated $84.9M.
  • Axa fully exited Life Storage, Inc. in Q3 2023, selling an estimated $19.3M.
  • Axa's ten largest holdings make up 23% of its $28.5B portfolio in Q3 2023.
  • Axa opened 104 new positions and closed 123 in Q3 2023.
  • Axa's portfolio value fell 5.5% quarter-over-quarter to $28.5B.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.